BDI-BioLife Science

BDI-BioLife Science is an Austrian biotechnology company specializing in the development and production of high-quality algae-based ingredients for the life science industry. The company operates one of the largest closed algae production facilities in Europe, utilizing proprietary photobioreactor technology to ensure controlled and sustainable cultivation. Its flagship product, ASTAFIT, is a premium natural astaxanthin derived from the microalgae Haematococcus pluvialis, targeted at the nutraceutical and cosmetic markets. BDI-BioLife Science focuses on providing science-backed, high-purity antioxidants to support human health and well-being. The company offers both raw materials and customized formulations, maintaining full traceability and adherence to strict European quality standards. As a subsidiary of BDI-Holding, it leverages extensive engineering expertise to optimize biological production processes.